The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriuchi, M.
Right arrow Articles by Moriuchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriuchi, M.
Right arrow Articles by Moriuchi, H.
The Journal of Immunology, 2001, 166: 4231-4236.
Copyright © 2001 by The American Association of Immunologists

A Milk Protein Lactoferrin Enhances Human T Cell Leukemia Virus Type I and Suppresses HIV-1 Infection1

Masako Moriuchi2,* and Hiroyuki Moriuchi2,3,*,{dagger}

* Division of Medical Virology, Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Medical Sciences; and {dagger} Department of Pediatrics, Nagasaki University School of Medicine, Nagasaki, Japan

Human T cell leukemia virus type I (HTLV-I) and HIV-1, causative agents of adult T cell leukemia/lymphoma and AIDS, respectively, are transmitted vertically via breast milk. Here we demonstrate that lactoferrin, a milk protein that has a variety of antimicrobial and immunomodulatory activities, facilitates replication of HTLV-I in lymphocytes derived from asymptomatic HTLV-I carriers and transmission to cord blood lymphocytes in vitro. Transient expression assays revealed that lactoferrin can transactivate HTLV-I long terminal repeat promoter. In contrast, lactoferrin inhibits HIV-1 replication, at least in part, at the level of viral fusion/entry. These results suggest that lactoferrin may have different effects on vertical transmission of the two milk-borne retroviruses.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Hieshima, D. Nagakubo, T. Nakayama, A.-K. Shirakawa, Z. Jin, and O. Yoshie
Tax-Inducible Production of CC Chemokine Ligand 22 by Human T Cell Leukemia Virus Type 1 (HTLV-1)-Infected T Cells Promotes Preferential Transmission of HTLV-1 to CCR4-Expressing CD4+ T Cells
J. Immunol., January 15, 2008; 180(2): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. M. Novak, B. A. Donoval, P. J. Graham, L. A. Boksa, G. Spear, R. C. Hershow, H. Y. Chen, and A. Landay
Cervicovaginal Levels of Lactoferrin, Secretory Leukocyte Protease Inhibitor, and RANTES and the Effects of Coexisting Vaginoses in Human Immunodeficiency Virus (HIV)-Seronegative Women with a High Risk of Heterosexual Acquisition of HIV Infection
Clin. Vaccine Immunol., September 1, 2007; 14(9): 1102 - 1107.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Johansson, M. Jonsson, M. Marttila, D. Persson, X.-L. Fan, J. Skog, L. Frangsmyr, G. Wadell, and N. Arnberg
Adenoviruses Use Lactoferrin as a Bridge for CAR-Independent Binding to and Infection of Epithelial Cells
J. Virol., January 15, 2007; 81(2): 954 - 963.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. H. Kazmi, J. R. Naglik, S. P. Sweet, R. W. Evans, S. O'Shea, J. E. Banatvala, and S. J. Challacombe
Comparison of Human Immunodeficiency Virus Type 1-Specific Inhibitory Activities in Saliva and Other Human Mucosal Fluids
Clin. Vaccine Immunol., October 1, 2006; 13(10): 1111 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Moriuchi and H. Moriuchi
Induction of Lactoferrin Gene Expression in Myeloid or Mammary Gland Cells by Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax: Implications for Milk-Borne Transmission of HTLV-1
J. Virol., July 15, 2006; 80(14): 7118 - 7126.
[Abstract] [Full Text] [PDF]


Home page
J Hum LactHome page
S. U. Hartmann, C. M. Berlin, and M. K. Howett
Alternative Modified Infant-Feeding Practices to Prevent Postnatal Transmission of Human Immunodeficiency Virus Type 1 Through Breast Milk: Past, Present, and Future
J Hum Lact, February 1, 2006; 22(1): 75 - 88.
[Abstract] [PDF]


Home page
J. Virol.Home page
M. Moriuchi and H. Moriuchi
Cell-Type-Dependent Effect of Transforming Growth Factor {beta}, a Major Cytokine in Breast Milk, on Human Immunodeficiency Virus Type 1 Infection of Mammary Epithelial MCF-7 Cells or Macrophages
J. Virol., December 1, 2004; 78(23): 13046 - 13052.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Moriuchi and H. Moriuchi
Seminal Fluid Enhances Replication of Human T-Cell Leukemia Virus Type 1: Implications for Sexual Transmission
J. Virol., November 15, 2004; 78(22): 12709 - 12711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.